AI-assisted international press reviewPress review

ADM to Showcase Innovations at Goldman Sachs Conference 2025

ADM, a leader in plant technology and agribusiness, will participate in the Goldman Sachs Industrials & Materials Conference 2025. On December 3rd in New York, join our fireside chat at 3:30 PM ET to explore our innovations in nutrition, health, and sustainability. Watch the live webcast at adm.com and discover how we are strengthening agricultural supply chains for a greener future. A replay will be available. Contact our media relations for more information.

Source: Adm, published under the title "ADM to Present at 2025 Goldman Sachs Industrials & Materials..." - 25 November 2025

Novartis Unveils Pioneering Advances in Hematology and Oncology at ASH and SABCS

Novartis is revolutionizing treatments in hematology and oncology: Unprecedented data from over 70 abstracts presented at ASH and SABCS 2025, including 11 oral presentations and a late-breaker for ianalumab in ITP. Promising results for patients with immune thrombocytopenia, chronic myeloid leukemia, and breast cancers, featuring advancements like the VAYHIT2 and NATALEE trials. These innovations aim to transform care and enhance quality of life, as explained by Mark Rutstein, head of oncology development at Novartis. Breakthroughs that redefine the future of personalized medicine.

Source: Novartis, published under the title "Novartis data underscore pioneering scientific innovation in..." - 25 November 2025

Imfinzi: First Immunotherapy Approved for Early Gastric Cancers

AstraZeneca's Imfinzi revolutionizes gastric cancer treatment: a 29% reduction in the risk of progression, recurrence, or death, and a 22% reduction in the risk of death, according to results from the Phase III MATTERHORN trial. This combination with FLOT chemotherapy is now approved in the United States for early stages (II, III, IVA), offering improved survival and new hope for patients. A major clinical breakthrough, validated by ASCO and ESMO.

Source: Astrazeneca, published under the title "Imfinzi approved in the US as first and only perioperative i..." - 24 November 2025

Dupixent: First Innovation in 10 Years for Chronic Urticaria in the EU

Dupixent from Sanofi and Regeneron: A breakthrough for patients with chronic spontaneous urticaria in Europe! Approved by the European Commission as the first targeted treatment in over a decade, based on phase 3 studies showing significant reductions in itching and hives in adolescents and adults, despite antihistamines. A key advancement for the 270,000 affected individuals, inhibiting type 2 inflammation. Available as a first-line option for a more controlled life.

Source: Sanofi, published under the title "Press Release: Sanofi and Regeneron’s Dupixent approved as t..." - 24 November 2025

Kraft Mac & Cheese: The "Best of All" in a Revolutionary Campaign

With John Mulaney as the voiceover, Kraft Mac & Cheese's "Best Thing Ever" campaign celebrates its irresistible flavor, ease of use, and affordability, proving that no dish has matched this American classic for nearly 90 years. Humorous ads compare Kraft to iconic life moments, like parties or trips, asserting it remains the undisputed champion of comfort food. The initiative expands with cultural activations, such as "Mac Friday" at Walmart, turning deals into a feast of indulgence accessible to all. A creative platform that honors the brand's legacy while reinforcing its everyday role in households. Follow @kraft_macandcheese for more info!

Source: Kraft Heinz, published under the title "Kraft Mac & Cheese Proves it’s the 'Best Thing Ever’ in Bold..." - 24 November 2025

CIMIC 2025 Finalists: Three Emerging Talents from CPB Contractors

Three graduates from CPB Contractors shine as finalists for the CIMIC Group Graduate of the Year 2025 Award! Kezia Evans, an electrical engineer, excels on the SPARK project with her expertise in smart systems; Lara Bouwer, a sustainability specialist, innovates at the Paradise Dam by developing environmental reporting tools; and Tom Luchetti, an engineer, impresses with his leadership in meetings and risk reviews. Sarah O'Neil, Executive General Manager, praises their energy, innovation, and collaboration, seeing them as the future leaders of construction. The event celebrating these talents will take place on November 25, marking an inspiring recognition for a promising generation!

Source: Cimic, published under the title "Emerging Leaders: Three CPB Contractors Graduates named fina..." - 24 November 2025

Novartis: FDA Approves Itvisma® for SMA Across All Ages

Novartis revolutionizes spinal muscular atrophy treatment: Itvisma, a one-time gene therapy, has been approved by the FDA to enhance motor function in children, teens, and adults. This innovation replaces the SMN1 gene, providing lasting stabilization and reducing the need for chronic treatments, marking a significant advancement for SMA patients.

Source: Novartis, published under the title "Novartis receives FDA approval for Itvisma®, the only gene r..." - 24 November 2025

Merck Innovates in Oral Treatment for Myasthenia Gravis

Cladribine capsules represent a promising advancement for generalized myasthenia gravis, a rare autoimmune disease. Merck announces that this potential first oral treatment has received Fast Track and Orphan Drug designations from the FDA, while establishing a patient council to guide development. Global clinical trials, such as MyClad, aim to provide an innovative option targeting B and T cells to reduce inflammation and improve patients' quality of life. A crucial collaboration with patient organizations and wearable technologies could expedite access to this treatment. Merck is committed to placing patients' voices at the heart of therapeutic innovation.

Source: Merck, published under the title "Merck Takes Patient-Directed Approach to Bring Innovation to..." - 24 November 2025

Bayer's Asundexian: A Breakthrough Against Recurrent Strokes

Bayer's Asundexian: a promising advancement in the prevention of ischemic strokes. The OCEANIC-STROKE study reveals a significant reduction in stroke risk without an increase in major bleeding compared to placebo with antiplatelet therapy. This is the first successful Phase III study for a Factor XIa inhibitor, and Bayer is preparing global authorization requests and plans to present at a scientific congress. A key milestone for patients at recurrent risk.

Source: Bayer, published under the title "Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints..." - 22 November 2025

Tyson Foods Restructures Network to Boost Sustainable Farming

Tyson Foods is reorganizing its beef production for a sustainable future: closing the Lexington plant, converting Amarillo to full-capacity mode, and increasing volumes elsewhere. Support for employees includes relocation and job offers, while ensuring affordable quality protein for future generations. A key step towards increased efficiency in agribusiness.

Source: Tyson Foods, published under the title "Tyson Foods Announces Network Changes to Strengthen Long-Ter..." - 22 November 2025

Auτonomy Study on Alzheimer Halted After Disappointing Results

Auτonomy Study Stopped: Johnson & Johnson Faces Setback with Innovative Alzheimer Treatment Titusville, N.J. – The pioneering Auτonomy pilot study, focused on early Alzheimer’s targeted approach, has been halted after disappointing results: posdinemab failed to show statistically significant effects on clinical decline. These initial analyses highlight the complexity of the disease and promise crucial insights for future research. Johnson & Johnson, committed for nearly 30 years, reaffirms its dedication to transforming care and commends the efforts of patients, caregivers, and involved teams. A comprehensive data evaluation will soon be shared with the scientific community.

Source: J&j - 21 November 2025

Mechanization & Robotics

AGCO Announces Its Participation in the 2025 UBS Industry Conference

AGCO, a major player in the design and distribution of agricultural machinery, will participate in the UBS 2025 conference on December 2. This event will highlight innovations in precision agricultural technologies, featuring a presentation by its CFO, Damon Audia. Investors will have the opportunity to follow this event live on AGCO's website, which recorded a revenue of $11.7 billion in 2024, underscoring its key role in agricultural sustainability.

Source: Agco, published under the title "AGCO to Present at the UBS 2025 Global Industrials & Transpo..." - 21 November 2025

Topping Out Celebration: New Nissan Stadium Takes Shape!

Tennessee Builders Alliance celebrates a historic milestone: the topping out of the new Nissan Stadium, future stronghold of the Tennessee Titans. With over 12,400 beams and 18,000 tons of steel laid, this innovative project transforms Nashville's East Bank into a vibrant hub. Thousands of workers, local businesses, and officials unite their efforts for a high-tech stadium featuring a translucent roof and community spaces, promising concerts, games, and sustainable economic growth for the region. A collaborative advancement that inspires the future!

Source: Hochtief, published under the title "Tennessee Builders Alliance and Tennessee Titans Celebrate T..." - 21 November 2025

First in New Zealand: Wastewater Heat for Parakiore

Parakiore: The next-generation sports center in New Zealand that transforms wastewater into renewable energy! With an innovative thermal recovery system, it produces heated water at 50°C and chilled water at 60°C, reducing traditional consumption by up to 3 MW. A first of its kind in the country and the largest in Australasia, this pioneering facility ensures comfort, efficiency, and sustainability for water sports and the community. A lesson in green innovation for the future!

Source: Cimic, published under the title "New Zealand’s first wastewater heat recovery system heats th..." - 21 November 2025

Pepsi Prebiotic Cola: Exclusive Launch for Black Friday!

Dive into agritech innovation with Pepsi Prebiotic Cola, a drink enriched with plant-based prebiotics for bold wellness. Available starting November 28 on Amazon, Walmart, TikTok, and select Kroger, DashMart, and GoPuff locations – while supplies last. Don’t miss the exclusive spot during Black Friday Football on Prime Video: add it to your cart with one click for an irresistible refreshment!

Source: Pepsico, published under the title "Pepsi® prebiotic cola goes on sale nationwide this Black Fri..." - 21 November 2025

AstraZeneca Invests $2 Billion in Maryland for 2,600 Jobs

AstraZeneca accelerates the production of cancer, rare, and chronic disease medications with a $2 billion investment in Maryland. The expansion of the Frederick site and the construction of a new high-tech facility in Gaithersburg will create 300 skilled jobs, support 2,600 local roles, and integrate AI, automation, and data analytics to strengthen the U.S. supply chain and promote innovative therapies by 2029. This project, the fourth in the U.S. this year, reinforces AstraZeneca's $50 billion commitment to R&D and manufacturing.

Source: Astrazeneca, published under the title "AstraZeneca plans $2 billion manufacturing investment in Mar..." - 20 November 2025

UGL: Safety at the Heart of Operations, Employee Recognized for Vigilance

At UGL, safety remains the foundation of innovation in agritech and engineering: Mitch McSweeney, a grade 6 electrician, receives a UGL Very Best award for averting an accident risk during the movement of aluminum struts. His alert, praised by Brendan Thorburn, strengthens our critical risk management guidelines and promotes a shared culture of vigilance, essential for protecting our teams in plant technology projects. United for safer work environments!

Source: Cimic - 20 November 2025

Gatorade Accelerates Women's Sports with Lisa Billard in F1 Academy

Gatorade is committed to the future of female athletes: Exclusive support for 16-year-old prodigy Lisa Billard from F1 ACADEMY™! As the new champion of French F4 and the first woman to win in Junior Karting, she will receive scientific support in hydration and nutrition through the GSSI Institute. This partnership, part of "Fuel Tomorrow," aims to bridge inequalities and inspire millions of young female athletes to shine on the tracks. Gatorade, the official partner for 2026, proves that equity starts with tailored resources!

Source: Pepsico, published under the title "Gatorade® aims to accelerate women’s sports through partners..." - 20 November 2025

Community Engagement: North District Hospital Volunteers in Hong Kong

The North District Hospital expansion project team in Hong Kong spread joy and warmth among the residents of the Buddhist Li Chong Yuet Ming nursing home. Volunteers packed gift bags and shared unforgettable moments, exchanging stories and smiles. At Leighton Asia, we are not just building infrastructure, but also sincere connections within communities. A huge thank you to all the volunteers for their generosity and positive impact!

Source: Cimic - 20 November 2025

Young Leaders Explore Innovation of the Warringah Freeway in Australia

Exclusive exploration behind the scenes of the Warringah Freeway Upgrade: over 60 young professionals discover the challenges, innovations, and solutions for smooth traffic in Sydney, featuring guided tours, safety workshops, and discussions on the future of road infrastructure. An inspiring partnership between Roads Australia and experts to train the next generation of transport leaders. Insights on managing 250,000 daily users and the technological advancements transforming urban networks.

Source: Cimic, published under the title "Emerging infrastructure leaders tour Warringah Freeway Upgra..." - 20 November 2025